Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Xorimax 250mg coated tablets

Approval Number

SIN13287P

Drug Name

Xorimax 250mg coated tablets

Product Name

Xorimax 250mg coated tablets

Approval Date

June 1, 2007

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, COATED

Route of Administration

ORAL

Medical Information

ATC Code

J01DC02

ATC Item Name

cefuroxime

Manufacturer Information

Pharmaceutical Manufacturer

SANDOZ SINGAPORE PTE. LTD.

Manufacturers

Sandoz Private Limited (Intermediate)

Pencef Pharma GmbH

Sandoz GmbH

Aurobindo Pharma Limited (Intermediate)

Active Ingredients

Ingredient Name

CEFUROXIME AXETIL 300.72 mg EQV CEFUROXIME

Strength

250 mg

Drug MonographCefuroxime

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Xorimax 250mg coated tablets - HSA Approval | MedPath